TherapeuticsMD (TXMD) Gross Profit (QoQ) (2011 - 2023)
TherapeuticsMD (TXMD) Gross Profit (QoQ) (2011 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1,047.17% |
| Sep 30, 2023 | -112.13% |
| Jun 30, 2023 | 5.05% |
| Mar 31, 2023 | -99.39% |
| Mar 31, 2022 | 3.82% |
| Dec 31, 2021 | -30.72% |
| Sep 30, 2021 | 6.65% |
| Jun 30, 2021 | 24.31% |
| Mar 31, 2021 | -10.70% |
| Dec 31, 2020 | 5.81% |
| Sep 30, 2020 | 154.93% |
| Jun 30, 2020 | -33.92% |
| Mar 31, 2020 | -26.78% |
| Dec 31, 2019 | -41.54% |
| Sep 30, 2019 | 361.18% |
| Jun 30, 2019 | 51.70% |
| Mar 31, 2019 | -23.07% |
| Dec 31, 2018 | 49.15% |
| Sep 30, 2018 | -16.14% |
| Jun 30, 2018 | 5.42% |